Skip to main navigation Skip to search Skip to main content

Correction: Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand (Cancer Gene Therapy, (2021), 28, 6, (590-601), 10.1038/s41417-020-00239-8)

  • Junhui Yu
  • , Kui Yang
  • , Jianbao Zheng
  • , Wei Zhao
  • , Xuejun Sun
  • The First Affiliated Hospital of Xi’an Jiaotong University

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)871-872
Number of pages2
JournalCancer Gene Therapy
Volume29
Issue number6
DOIs
StatePublished - Jun 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this